CHO/Human CD32a (131H) Stable Cell Line (Medium Expression)

ユーザーレビュー
製品番号/仕様
価格
数量
SCCHO-ATP061M-2Vials (1Vial X 2)
$5540.00
ETA of in-stock products:2 business days
総アイテム数 製品金額$ 0

製品詳細

    1. Genetically modified cell lines best reflect MOA (Mechanism of Action)
    2. Higher activity and larger assay window for robust and reproducible cell-based bioassay
    3. Comprehensive application data to support assay development and validation
    4. Full tracible record, stringent quality control and validated cell passage stability
    5. Parental cell line legally obtained from internationally recognized cell resource bank and commercially licensed
    6. Global commercial license assistance whenever regulatory filing is required
  • Description

    The CHO/Human CD32a (131H) Stable Cell Line was engineered to express the receptor full length human CD32a (Uniprot: P12318-1), with different levels of CD32a (131H) expression (High, Medium, Low), which can be used to test agonist antibody whether in a CD32a (131H)-dependent manner to strengthen the agonistic activity. When co-cultured with Human 4-1BB HEK293 Reporter Cell and anti-4-1BB agonist antibody, the anti-4-1BB antibody can be crosslinked, thereby strengthening 4-1BB pathway-activated luminescence.

  • Application

    • Useful for cell-based CD32a (131H) binding assay

    • Useful for CD32a (131H) -mediated crosslinking

    Fc gamma RIIA / CD32a Assay Principles

  • Growth Properties

    Adherent

  • Selection Marker

    Hygromycin B (20 μg/mL)

  • Complete Growth Medium

    F-12K+ 10% FBS

  • Freeze Medium

    Serum-free cell cryopreservation medium

  • Quantity

    1 vial contains at least 5×10^6 cells in 1 mL serum-free cryopreservation medium

  • Storage

    Frozen in liquid nitrogen.

  • Mycoplasma Testing

    Negative

  • Sterility Testing

    Negative

  • Instructions for Use

    See data sheet for detailed culturing and assay protocol.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

お客様はこちらも閲覧

データ表示

  • Receptor Assay

     Fc gamma RIIA / CD32a FACS

    Expression analysis of human CD32a on CHO/Human CD32a (131H) Stable Cell Line by FACS.
    Cell surface staining using PE-labeled anti-human CD32a antibody was performed on CHO/Human CD32a (131H) Stable Cell Line with different expression levels: CHO/Human CD32a (131H) Stable Cell Line (Low Expression); CHO/Human CD32a (131H) Stable Cell Line (Medium Expression); CHO/Human CD32a (131H) Stable Cell Line (High Expression).

    Protocol
  • Application

     Fc gamma RIIA / CD32a APPLICATION

    Bioactivity analysis of anti-human 4-1BB antibody through CHO/Human CD32a (131H) Stable Cell Line (Medium Expression) crosslinking to test whether in a CD32a (131H) -dependent manner to strengthen the agonistic activity.
    The EC50 of anti-human 4-1BB antibody is approximately 0.05 μg/mL through CHO/Human CD32a (131H) Stable Cell Line (Medium Expression) crosslinking.

    Protocol
*Please contact us if you are interested in related cell pool service.

ユーザーレビュー
コメントを投稿

重要な声明

  • Limited Use&License Disclosure

    BY USE OF THIS PRODUCT, RESEARCHER AGREES TO BE BOUND BY THE FOLLOWING TERMS OF LIMITED USE OF THIS CELL LINE PRODUCT.

    1. If the researcher is not willing to accept the terms of limited use of this cell line product, and the product is unused, ACRO will accept return of the unused product.
    2. Researchers may use this product for research use only, no commercial use is allowed. "Commercial use" means any and all uses of this product and derivatives by a party for profit or other consideration and may include but is not limited to use in: (1) product manufacture; and (2) to provide a service, information or data; and/or resale of the product or its derivatives, whether or not such product or derivatives are resold for use in research.
    3. This cell line is neither intended for any animal or human therapeutic purposes nor for any direct human in vivo use. You have no right to share, modify, transfer, distribute, sell, sublicense, or otherwise make the cell line available for use to other researchers, laboratories, research institutions, hospitals, universities, or service organizations.
    4. ACROBIOSYSTEMS MAKES NO WARRANTIES OR REPRESENTATIONS OF ANY KIND, EITHER EXPRESSED OR IMPLIED, WITH RESPECT TO THE SUITABILITY OF THE CELL LINE FOR ANY PARTICULAR USE.
    5. ACROBIOSYSTEMS ACCEPTS NO LIABILITY IN CONNECTION WITH THE HANDLING OR USE OF THE CELL LINE.
    6. Modifications of the cell line, transfer to a third party, or commercial use of the cell line may require a separate license and additional fees. Please contact order@acrobiosystems.com for further details.

最新の進展

 
医薬品開発の進捗
  • 英語名:

    Low affinity immunoglobulin gamma Fc region receptor II-a

  • カテゴリ:

  • 市販の医薬品数:

    0 詳細

  • 治験医薬品数:

    2 詳細

  • 最新の開発ステージ:

    Phase 1 Clinical

お問い合わせ
医薬品候補ライセンス
他の関連情報
  • 製品情報
  • 製品詳細
  • お客様はこちらも閲覧
  • データ表示
  • ユーザーレビュー
  • 重要な声明
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8